Now I want to hear from you: Are you someone who has taken or is currently taking a GLP-1 agonist
This is where MeAgain's GLP-1 app fits in
The most frequently reported adverse events involve the gastrointestinal systemnausea, vomiting, constipation, and diarrheawhich affect 25-70% of users depending on dose escalation speed
This is a company doing the math and realising it doesn't add up
The article also expects a clinic to document contraindications in writing before therapy begins
While GLP-1s are well known for supporting weight loss, research also shows benefits for blood sugar control, cardiovascular health, and inflammation reduction, longevity, cognition and metabolic health